Iovance Biotherapeutics
Nadine Mubayed is currently working as the Manager of SEC Reporting and SOX Compliance at Iovance Biotherapeutics, Inc. Previously, Nadine held positions as a Senior Accountant at Proteus Digital Health, Inc. and Core-Mark International. Prior to their corporate roles, Nadine worked as a Senior Assurance Associate at EY. Nadine also gained experience as an Accounting Intern at Hamid Azad, CPA. In addition to their professional experience, Nadine also worked as an Accounting Tutor at Notre Dame de Namur University. Nadine holds a Bachelor of Science in Business Administration with a concentration in Management and a minor in Accounting from Notre Dame de Namur University.
This person is not in the org chart
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.